Will Rigetti be selected for DARPA QBI Phase B by December 31, 2026?

DARPA cited specific technical gaps: error correction and long-range coupling. These are fundamental physics challenges, not engineering optimizations that can be solved with a chip redesign. The QBI Phase B emphasizes fault-tolerant quantum computing (2033 timeline), while Rigetti optimizes for near-term quantum advantage — a strategic misalignment. CEO's optimism ('by end of this year or thereabouts') is based on addressable feedback, but DARPA's assessment was concrete and specific. Competitors already in Phase B are gaining resources and making progress. Rolling admission helps but the gaps are substantive.

The CEO's confidence is notable — he would not publicly commit to 'by end of this year' without some basis for believing the gaps are addressable. The 108Q deployment and fidelity improvements through 2026 may provide evidence DARPA needs. The Riverlane partnership for error correction could address one of the two cited gaps. However, long-range coupling is a more fundamental architectural challenge for superconducting systems. DARPA's rolling admission process helps, but the timeline for demonstrated improvements is tight. I weight CEO confidence at modest discount (management optimism) but acknowledge the specific feedback gives Rigetti a roadmap for re-entry.

DARPA programs have rigorous evaluation criteria and the Phase B exclusion was a considered judgment, not an oversight. The error correction and long-range coupling gaps are areas where competitors (IBM, Quantinuum) have demonstrated more advanced capabilities. Rigetti's strengths (gate speed, chiplets, Fab-1) are not the dimensions DARPA Phase B prioritizes. The 10-month window from March to December 2026 is short for demonstrating substantive progress on fundamental physics challenges. CEO optimism may reflect aspiration rather than concrete progress metrics.

DARPA is a sophisticated evaluator that identified specific gaps. Error correction and long-range coupling represent multi-year research programs, not quick fixes. The CEO's 'by end of this year' timeline feels optimistic given the scope of the challenges. Competitors like IBM and Quantinuum have dedicated error correction teams with years of head start. The strategic mismatch between Rigetti's near-term QA focus and DARPA's FTQC goals is structural, not addressable by incremental improvements.

The rolling nature of Phase B admission is the main factor preventing a lower estimate. DARPA explicitly gave Rigetti a list of things to address, suggesting a re-entry pathway exists. If Rigetti demonstrates meaningful error correction progress through 2026 (potentially via the Riverlane partnership), a late-2026 selection is conceivable. However, the base rate for companies excluded from competitive DARPA programs being re-admitted within 12 months is low. The CEO's public optimism may be partly for investor relations purposes.

The gap between CEO optimism and the technical reality of error correction challenges creates uncertainty. DARPA cited two specific areas — if Rigetti could address one (error correction via Riverlane) but not the other (long-range coupling, which is architectural for superconducting systems), it may still not meet the bar. The timeline is aggressive for physics breakthroughs. Low confidence because the DARPA evaluation process is opaque and rolling — a surprise positive is possible but fundamentally unlikely.

DARPA excluded Rigetti for specific technical reasons. Error correction and long-range coupling are fundamental challenges. CEO optimism is a weak signal against a concrete negative evaluation. Short timeline for meaningful progress on physics challenges. Competitors have head start.

Rolling admission provides hope but the gaps are substantive. Error correction via Riverlane could help but needs demonstration. Long-range coupling is harder for superconducting architectures. The 10-month window from March to December is tight. CEO commitment is notable but may reflect aspiration.

Base rate analysis: companies excluded from competitive government programs rarely re-enter within 12 months. DARPA's assessment was specific and based on demonstrated capability gaps. Rigetti's roadmap focuses on near-term quantum advantage, not the fault-tolerant QC that DARPA Phase B requires. The strategic misalignment is the core issue.